Login / Signup

Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer.

Ming-Yii HuangHsin-Hua LeeHsiang-Lin TsaiChing-Wen HuangYung-Sung YehCheng-Jen MaChun-Ming HuangChiao-Yun ChenJoh-Jong HuangJaw-Yuan Wang
Published in: Radiation oncology (London, England) (2018)
Patients with LARC in the upper rectum who underwent NACRT followed by TME had similar DFS and a trend toward longer OS, compared with those who had middle/lower rectal lesions. Furthermore, FOLFOX may yield superior results than fluoropyrimidine based regimen during NACRT. NACRT might be an alternative option for patients with LARC in the upper rectum as it has a favorable pathological complete response rate and comparable clinical outcomes when compared with patients with LARC in middle/lower rectum.
Keyphrases
  • rectal cancer
  • locally advanced
  • neoadjuvant chemotherapy
  • phase ii study
  • squamous cell carcinoma
  • radiation therapy
  • patients undergoing
  • metastatic colorectal cancer